EXPRESSION OF THE HER-2/NEU/C-ERBB-2 ONCOGENE IN BREAST-CANCER

被引：0
|
作者：
PRESS, MF
GODOLPHIN, W
SLAMON, DJ
机构：
[1] UNIV SO CALIF,SCH MED,LOS ANGELES,CA 90033
[2] VANCOUVER GEN HOSP,VANCOUVER V5Z 1M9,BC,CANADA
[3] UNIV CALIF LOS ANGELES,MED CTR,LOS ANGELES,CA 90024
来源：
LABORATORY INVESTIGATION | 1989年 / 60卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A73 / A73
页数：1
相关论文
共 50 条
  • [41] The Role of c-erbB-2/HER2/neu in Breast Cancer Progression and Metastasis
    Suzanne A. Eccles
    Journal of Mammary Gland Biology and Neoplasia, 2001, 6 : 393 - 406
  • [42] ASSOCIATION OF MULTIPLE COPIES OF THE C-ERBB-2 ONCOGENE WITH SPREAD OF BREAST-CANCER
    ZHOU, DJ
    BATTIFORA, H
    YOKOTA, J
    YAMAMOTO, T
    CLINE, MJ
    CANCER RESEARCH, 1987, 47 (22) : 6123 - 6125
  • [43] c-erbB-2 (HER-2/neu) immunohistochemistry in invasive breast cancer: is there concordance between standard sections and tissue microarrays?
    Selvarajan, Sathiyamoorthy
    Tan, Soo Yong
    Sii, Lang Hiong
    Tan, Puay Hoon
    PATHOLOGY, 2006, 38 (04) : 316 - 320
  • [44] Experience with Her-2/neu (c-erbB-2) gene status evaluation in breast cancer samples with unusual FISH results
    Trojanec, R.
    Kolar, Z.
    Palkova, V.
    Berkovcova, J.
    Braunerova, B.
    Tichy, M.
    Bouchalova, K.
    Krejci, V.
    Melichar, B.
    Hajduch, M.
    CHROMOSOME RESEARCH, 2009, 17 : 126 - 126
  • [45] Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: A new prognostic factor
    Meden, H
    Kuhn, W
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1997, 71 (02): : 173 - 179
  • [46] Overexpression of the oncogene c-erbB-2 (HER2/neu) and response to chemotherapy in patients with ovarian cancer
    Meden, H
    Marx, D
    Roegglen, T
    Schauer, A
    Kuhn, W
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1998, 17 (01) : 61 - 65
  • [47] Prognostic significance of c-erbB-2 (HER-2/neu) oncoprotein in benign and malignant breast tumor tissue
    Simícková, M
    Pecen, L
    Cernoch, M
    Vagunda, V
    Pochmon, D
    Vermousek, I
    Lang, B
    Pacovsky, Z
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1999, 14 (04): : 13 - 22
  • [48] VARIABLE EXPRESSION OF EGFR AND HER-2/NEU IN PRIMARY AND METASTATIC BREAST-CANCER
    LOWER, EE
    HEFFELFINGER, SC
    MILLER, MA
    FENOGLIOPREISER, CM
    CLINICAL RESEARCH, 1994, 42 (03): : A424 - A424
  • [49] Increased sensitivity to cisplatin in gastric cancer by antisense inhibition of the HER-2/neu (c-erbB-2) gene
    Funato, T
    Kozawa, K
    Fujimaki, S
    Miura, T
    Kaku, M
    CHEMOTHERAPY, 2001, 47 (04) : 297 - 303
  • [50] Comparative assays for the HER-2/neu oncogene status in breast cancer
    Vera-Román, JM
    Rubio-Martínez, LA
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2004, 128 (06) : 627 - 633
12345